Anna Palau

474 total citations
8 papers, 214 citations indexed

About

Anna Palau is a scholar working on Molecular Biology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Anna Palau has authored 8 papers receiving a total of 214 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Hematology and 1 paper in Public Health, Environmental and Occupational Health. Recurrent topics in Anna Palau's work include Acute Myeloid Leukemia Research (6 papers), Epigenetics and DNA Methylation (4 papers) and Protein Degradation and Inhibitors (3 papers). Anna Palau is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Epigenetics and DNA Methylation (4 papers) and Protein Degradation and Inhibitors (3 papers). Anna Palau collaborates with scholars based in Spain, Sweden and Germany. Anna Palau's co-authors include Marcus Buschbeck, Jeannine Diesch, Anne-Kathrin Garz, Katharina S. Götze, Roberto Malinverni, Vanesa Valero, Catherine Creppe, Andreas Lennartsson, Lucia Cavelier and Françesc Solé and has published in prestigious journals such as PLoS Genetics, Leukemia and Oncotarget.

In The Last Decade

Anna Palau

8 papers receiving 212 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Palau Spain 5 179 83 23 16 14 8 214
Zachary S. Bohannan United States 7 85 0.5× 68 0.8× 21 0.9× 14 0.9× 17 1.2× 13 142
Pasit Phiasivongsa United States 4 176 1.0× 50 0.6× 16 0.7× 16 1.0× 13 0.9× 6 214
Anne-Kathrin Garz Germany 4 126 0.7× 93 1.1× 15 0.7× 19 1.2× 10 0.7× 5 167
Marion Heiß-Neumann Germany 4 146 0.8× 139 1.7× 19 0.8× 28 1.8× 15 1.1× 13 201
Daria G. Valerio United States 5 279 1.6× 105 1.3× 39 1.7× 20 1.3× 14 1.0× 8 317
Maria Grazia D’Errigo Italy 4 106 0.6× 67 0.8× 17 0.7× 13 0.8× 13 0.9× 9 176
Jianping Lan China 8 106 0.6× 99 1.2× 18 0.8× 21 1.3× 39 2.8× 20 197
Yuki Kagiyama Japan 7 126 0.7× 70 0.8× 22 1.0× 66 4.1× 15 1.1× 10 202
Gabriela Krivdova Canada 5 92 0.5× 70 0.8× 18 0.8× 31 1.9× 8 0.6× 12 144
Petra Tschanter Germany 5 117 0.7× 53 0.6× 13 0.6× 6 0.4× 20 1.4× 8 153

Countries citing papers authored by Anna Palau

Since Specialization
Citations

This map shows the geographic impact of Anna Palau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Palau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Palau more than expected).

Fields of papers citing papers by Anna Palau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Palau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Palau. The network helps show where Anna Palau may publish in the future.

Co-authorship network of co-authors of Anna Palau

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Palau. A scholar is included among the top collaborators of Anna Palau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Palau. Anna Palau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Palau, Anna, Michael Lidschreiber, Katja Lidschreiber, et al.. (2023). Perturbed epigenetic transcriptional regulation in AML with IDH mutations causes increased susceptibility to NK cells. Leukemia. 37(9). 1830–1841. 4 indexed citations
2.
Mareschal, Sylvain, Anna Palau, Johan Lindberg, et al.. (2021). Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML. Blood Advances. 5(4). 1003–1016. 12 indexed citations
3.
Palau, Anna, et al.. (2020). A regulatory role for CHD2 in myelopoiesis. Epigenetics. 15(6-7). 702–714. 6 indexed citations
4.
Palau, Anna, Anne-Kathrin Garz, Jeannine Diesch, et al.. (2017). Polycomb protein RING1A limits hematopoietic differentiation in myelodysplastic syndromes. Oncotarget. 8(70). 115002–115017. 4 indexed citations
5.
Diesch, Jeannine, et al.. (2016). A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers. Clinical Epigenetics. 8(1). 71–71. 123 indexed citations
6.
Palau, Anna, Mar Mallo, Laura Palomo, et al.. (2016). Immunophenotypic, cytogenetic, and mutational characterization of cell lines derived from myelodysplastic syndrome patients after progression to acute myeloid leukemia. Genes Chromosomes and Cancer. 56(3). 243–252. 9 indexed citations
7.
Palau, Anna, Manuel Perucho, Manel Esteller, & Marcus Buschbeck. (2014). First Barcelona Conference on Epigenetics and Cancer. Epigenetics. 9(3). 468–475. 4 indexed citations
8.
Creppe, Catherine, Anna Palau, Roberto Malinverni, Vanesa Valero, & Marcus Buschbeck. (2014). A Cbx8-Containing Polycomb Complex Facilitates the Transition to Gene Activation during ES Cell Differentiation. PLoS Genetics. 10(12). e1004851–e1004851. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026